Cancer is now the most common cause of death in Ireland and yet more people than ever are living with it. Thanks to the research and the advancements made in detection and treatment, the rate of survival in Ireland continues to improve with over 170,000 people in Ireland living with and beyond cancer. With the impact of cancer reaching far beyond treatment how can we ensure the needs of cancer survivors are being met; that they can come back from treatment and thrive?
With an ageing population there needs to be a sustained focus on treatment and prevention of cancer. The successful development of new therapies is dependent on patients and medical centres able and willing to participate in clinical trials. This success can be seen in particular from new immunotherapy trials showing unprecedented benefits to cancer patients.
LIVING WITH.. is a flagship event series beginning in 2019 in partnership with ICON that aims to explore healthcare, the human experience and the future of disease treatment in a way that is engaging and drives the conversation. As part of our LIVING WITH series, this panel discussion will look at the latest developments in delivering a tailored approach to cancer care and diagnostics. We will not only speak to the researchers on the front lines of clinical trials but we will also hear about life after treatment and the impact cancer has on patients’ lives.
This discussion will be live-streamed through the Science Gallery Dublin Facebook page.
About Science Gallery Dublin
Established in 2008 by Trinity College Dublin, Science Gallery Dublin’s mission is to engage 15-25 year olds through the intersections of art and science. Since its opening, more than three million visitors to the nonprofit gallery have experienced 45 unique exhibitions, ranging from design and violence to light and love, and from contagion and biomimicry to the futures of the human species and play. At the heart of Science Gallery Dublin lies a rich network of collaborators: artists, designers, performers, academics, scientists, researchers and extraordinary colleagues located in Science Gallery nodes across the world.
ICON is a global provider of drug development solutions and services to pharmaceutical, biotechnology, medical device and government, and public health organisations. The company specialises in the strategic development, management, and analysis of programs that support clinical development – from compound selection to Phase I-IV clinical studies. Founded and headquartered in Dublin since 1990, ICON currently, operates from 90 locations in 37 countries and has approximately 13,680 employees.